CLOVER HEALTH INVESTMENTS, CORP. /DE - POS AM filing on 2021-06-21

Reverse Capitalization (Tables)

12 Months Ended

Dec. 31, 2020

Retroactive application of reverse capitalization to Consolidated Balance Sheets


Date	Description	As previously reported		1/7/21 conversion ratio		Reverse capitalized shares
12/31/2019	Convertible preferred shares authorized		75,136,086		2.0681		155,387,025
12/31/2019	Convertible preferred shares issued and outstanding		67,427,138		2.0681		139,444,346
12/31/2019	Common shares authorized		170,000,000		2.0681		351,572,668
12/31/2019	Common shares issued		42,877,665		2.0681		88,674,206
12/31/2019	Common shares outstanding		42,686,624		2.0681		88,279,119
12/31/2020	Convertible preferred shares authorized		75,136,086		2.0681		155,387,025
12/31/2020	Convertible preferred shares issued and outstanding		67,427,138		2.0681		139,444,346
12/31/2020	Common shares authorized		170,000,000		2.0681		351,572,668
12/31/2020	Common shares issued		43,505,291		2.0681		89,972,184
12/31/2020	Common shares outstanding		43,134,938		2.0681		89,206,266

Retroactive application of reverse capitalization to Consolidated Statements of Operations and Comprehensive Loss


Date	Description	As previously reported			1/7/21 conversion ratio		Reverse capitalized amounts
12/31/2019	Net loss per share attributable to common shareholders - basic and diluted	$	(8.56	)		2.0681	$	(4.14	)
12/31/2019	Basic and diluted weighted average number of common shares and common shares equivalents outstanding		42,469,175			2.0681		87,829,419
12/31/2020	Net loss per share attributable to common shareholders - basic and diluted	$	(3.18	)		2.0681	$	(1.54	)
12/31/2020	Basic and diluted weighted average number of common shares and common shares equivalents outstanding		42,886,067			2.0681		88,691,582

Retroactive application of reverse capitalization to Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders’ Deficit


Date	Description	As previously reported		1/7/21 conversion ratio		Reverse capitalized amounts
12/31/2018	Convertible preferred stock - shares		67,427,138		2.0681		139,444,346
12/31/2018	Common stock - shares		42,243,445		2.0681		87,362,592
12/31/2018	Common stock - amount	$	4		2.0681	$	9